Stanley C. Erck
2016
In 2016, Stanley C. Erck earned a total compensation of $3.9M as President, CEO and Interim CFO at Novavax, a 20% decrease compared to previous year.
Compensation breakdown
| Option Awards | $3,252,440 |
|---|---|
| Salary | $618,000 |
| Other | $7,379 |
| Total | $3,877,819 |
Erck received $3.3M in option awards, accounting for 84% of the total pay in 2016.
Erck also received $618K in salary and $7.4K in other compensation.
Rankings
In 2016, Stanley C. Erck's compensation ranked 2,330th out of 14,075 executives tracked by ExecPay. In other words, Erck earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,330 out of 14,075 | 83rd |
Division Manufacturing | 809 out of 5,489 | 85th |
Major group Chemicals And Allied Products | 239 out of 1,895 | 87th |
Industry group Drugs | 174 out of 1,538 | 89th |
Industry Biological Products, Except Diagnostic Substances | 35 out of 279 | 88th |
Source: SEC filing on April 30, 2018.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2016.